Nilsson B - Search Results

1

Breast cancer risk in women with a primary ovarian cancer--a case-control study.

Bergfeldt K, Nilsson B, Einhorn S, Hall P. Bergfeldt K, et al. Among authors: nilsson b. Eur J Cancer. 2001 Nov;37(17):2229-34. doi: 10.1016/s0959-8049(01)00282-9. Eur J Cancer. 2001. PMID: 11677112

2

Cancer incidence among Swedish patients exposed to radioactive thorotrast: a forty-year follow-up survey.

Nyberg U, Nilsson B, Travis LB, Holm LE, Hall P. Nyberg U, et al. Among authors: nilsson b. Radiat Res. 2002 Apr;157(4):419-25. doi: 10.1667/0033-7587(2002)157[0419:ciaspe]2.0.co;2. Radiat Res. 2002. PMID: 11893244

3

DNA pattern and dietary habits in patients with breast cancer.

Fürst CJ, Auer G, Nordevang E, Nilsson B, Holm LE. Fürst CJ, et al. Among authors: nilsson b. Eur J Cancer. 1993;29A(9):1285-8. doi: 10.1016/0959-8049(93)90074-p. Eur J Cancer. 1993. PMID: 8343269

4

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival.

Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlöf B, Ringborg UK. Ragnarsson-Olding BK, et al. Among authors: nilsson br. Cancer. 1999 Oct 1;86(7):1285-93. Cancer. 1999. PMID: 10506715

5

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features.

Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlöf B, Nilsson BR, Ringborg UK. Ragnarsson-Olding BK, et al. Among authors: nilsson br. Cancer. 1999 Oct 1;86(7):1273-84. Cancer. 1999. PMID: 10506714

6

Is there place for radiotherapy in the treatment of advanced ovarian cancer?

Einhorn N, Lundell M, Nilsson B, Ragnarsson-Olding B, Sjövall K. Einhorn N, et al. Among authors: nilsson b. Radiother Oncol. 1999 Dec;53(3):213-8. doi: 10.1016/s0167-8140(99)00144-9. Radiother Oncol. 1999. PMID: 10660201

7

Long-term follow-up of the Stockholm screening study on ovarian cancer.

Einhorn N, Bast R, Knapp R, Nilsson B, Zurawski V Jr, Sjövall K. Einhorn N, et al. Among authors: nilsson b. Gynecol Oncol. 2000 Dec;79(3):466-70. doi: 10.1006/gyno.2000.5983. Gynecol Oncol. 2000. PMID: 11104621

8

Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.

Avall-Lundqvist EH, Sjövall K, Nilsson BR, Eneroth PH. Avall-Lundqvist EH, et al. Among authors: nilsson br. Eur J Cancer. 1992;28A(10):1695-702. doi: 10.1016/0959-8049(92)90071-9. Eur J Cancer. 1992. PMID: 1389488

9

The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma.

Avall-Lundqvist EH, Silfverswärd C, Aspenblad U, Nilsson BR, Auer GU. Avall-Lundqvist EH, et al. Among authors: nilsson br. Eur J Cancer. 1997 Oct;33(11):1799-804. doi: 10.1016/s0959-8049(97)00161-5. Eur J Cancer. 1997. PMID: 9470836

10

Prognostic value of erb-B2 and myc amplification in breast cancer imprints.

Lönn U, Lönn S, Nilsson B, Stenkvist B. Lönn U, et al. Among authors: nilsson b. Cancer. 1995 Jun 1;75(11):2681-7. doi: 10.1002/1097-0142(19950601)75:11<2681::aid-cncr2820751107>3.0.co;2-r. Cancer. 1995. PMID: 7743470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,017 results

Search Page

Filters